661 results on '"Chibale, Kelly"'
Search Results
2. Antimalarial drug discovery: progress and approaches.
3. Author Correction: Antimalarial drug discovery: progress and approaches
4. AI can help to tailor drugs for Africa — but Africans should lead the way
5. The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages.
6. The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance.
7. The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics
8. First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa
9. Developing kinase inhibitors for malaria: an opportunity or liability?
10. Fostering drug discovery and development in Africa
11. Including African data in drug discovery and development
12. Thwarting protein synthesis leads to malaria parasite paralysis
13. Model‐Informed Approaches to Optimizing Therapeutics in the African Patient Populations.
14. The Tuberculosis Drug Accelerator at year 10: what have we learned?
15. MalDA, Accelerating Malaria Drug Discovery
16. Plasmodium Kinase Inhibitors as Potential Multistage Active Antimalarials
17. The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against Plasmodium falciparum.
18. Ongoing Implementation and Prospective Validation of Artificial Intelligence/Machine Learning Tools at an African Drug Discovery Center.
19. Antimicrobial evaluation of neutral and cationic iridium(III) and rhodium(III) aminoquinoline-benzimidazole hybrid complexes
20. Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity
21. Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents
22. The quest for the holy grail: new antitubercular chemical entities, targets and strategies
23. A preformulation co-crystal screening case study: Polymorphic co-crystals of an imidazopyridazine antimalarial drug lead with the coformer succinic acid
24. Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery
25. Design and synthesis of novel ferrocene-quinoline conjugates and evaluation of their electrochemical and antiplasmodium properties
26. hERG, Plasmodium Life Cycle, and Cross Resistance Profiling of New Azabenzimidazole Analogues of Astemizole
27. Tips for Getting Your Manuscript Accepted into ACS Medicinal Chemistry Letters
28. Structure elaboration of isoniazid: synthesis, in silico molecular docking and antimycobacterial activity of isoniazid–pyrimidine conjugates
29. Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box
30. Cocrystal and Salt Forms of an Imidazopyridazine Antimalarial Drug Lead
31. Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazoles
32. Call for Papers: Fungal Pathogens – Life Cycle, Infection, Host Immunity and Drug Discovery
33. Call for Papers: Exploring the Use of AI/ML Technologies in Medicinal Chemistry and Drug Discovery
34. Drug discovery in Africa tackles zoonotic and related infections
35. Pyrimidine-chloroquinoline hybrids: Synthesis and antiplasmodial activity
36. Reversed isoniazids: Design, synthesis and evaluation against Mycobacterium tuberculosis
37. Quinine fever
38. Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents
39. Medicinal chemistry progression of antimalarial hits from phenotypic whole cell screening of SoftFocus libraries
40. Preface
41. Preparation and Physicochemical Characterization of an Inclusion Complex Between Dimethylated β-Cyclodextrin and a Drug Lead From a New Class of Orally Active Antimalarial 3,5-Diaryl-2-Aminopyridines
42. Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl
43. Antimalarial Imidazopyridines Incorporating an Intramolecular Hydrogen Bonding Motif: Medicinal Chemistry and Mechanistic Studies
44. A Series of Spiropyrimidinetriones that Enhances DNA Cleavage Mediated by Mycobacterium tuberculosis Gyrase
45. Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in Plasmodium falciparum, and Synergize with Clinical Antimalarials
46. The 2022 H3D Symposium: Celebrating over a Decade of African-Led Infectious Disease Drug Discovery to Enhance Global Health
47. Fusidic acid-based drug combinations exhibit enhanced activity againstMycobacterium tuberculosis
48. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization
49. Antimalarial benzoheterocyclic 4-aminoquinolines: Structure–activity relationship, in vivo evaluation, mechanistic and bioactivation studies
50. Primaquine–pyrimidine hybrids: Synthesis and dual-stage antiplasmodial activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.